ID
7906
Descripción
E3F05 Second Primary Form Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA
Link
Palabras clave
Versiones (3)
- 26/8/12 26/8/12 - Philipp Bruland
- 9/1/15 9/1/15 - Martin Dugas
- 16/6/15 16/6/15 -
Subido en
9 de enero de 2015
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Brain and Central Nervous System Tumors NCT00978458 Registration - E3F05 Second Primary Form - 2926619v1.0
INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead
- StudyEvent: E3F05 Second Primary Form
Similar models
INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead
- StudyEvent: E3F05 Second Primary Form